UCB S.A. (UCB.BR) Dividend Yield, History & Forecast

UCB S.A. (UCB.BR) is a Biotechnology company in the Healthcare sector listed on the Euronext Brussels. It pays a current dividend yield of 0.47% ($1.01 per share annually (TTM)), with 16 years of consecutive dividend increases. The most recent ex-dividend date was May 4, 2026, with payment scheduled for May 6, 2026. The trailing twelve-month payout ratio is 16.9%; the market capitalization is approximately $46.83B.

Loading quote...

Frequently Asked Questions about UCB S.A. (UCB.BR)

What is UCB S.A.'s dividend yield?
UCB S.A. (UCB.BR) pays a current trailing twelve-month dividend yield of 0.47%, which works out to $1.01 per share annually based on the most recent payout schedule.
When does UCB S.A. pay its next dividend?
The most recent ex-dividend date was May 4, 2026. The next scheduled dividend payment date is May 6, 2026.
How many years has UCB S.A. increased its dividend?
UCB S.A. (UCB.BR) has increased its dividend for 16 consecutive years.
Is UCB S.A. a Dividend Aristocrat?
No. Dividend Aristocrat status requires an S&P 500 listing and 25 or more consecutive years of dividend increases. UCB S.A. (UCB.BR) currently has 16 years of consecutive increases.
What sector is UCB S.A. in?
UCB S.A. (UCB.BR) operates in the Healthcare sector, specifically the Biotechnology industry.
What is UCB S.A.'s dividend payout ratio?
UCB S.A. (UCB.BR)'s trailing twelve-month dividend payout ratio is 16.9%. The payout ratio measures what percentage of earnings is paid out as dividends — a lower ratio generally suggests a more sustainable dividend.